mRNA Vaccines for COVID-19
Recently, a rush of interim analyses from pharmaceutical companies Moderna and Pfizer/BioNTech has spurred optimism that a novel type of vaccine made from messenger RNA, known as mRNA, can offer high levels of protection by preventing COVID-19 among people who are vaccinated.
- Moderna’s new mRNA vaccine is almost 94.5% effective in large-scale trials. Similarly, Pfizer’s vaccine has also shown an efficacy of around 95%.
mRNA Vaccine Function
- mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, a mRNA vaccine teaches our cells how to make a protein or even just a portion ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 Kisan Kavach Suit
- 2 Hybrid Aerogel for Gold Extraction from E-Waste
- 3 New Breakthrough in Haemophilia Treatment
- 4 Cellular-Level Map of Growing Foetal Brains
- 5 India’s Zorawar Light Tank Hits Major Milestone
- 6 CE20 Cryogenic Engine: ISRO Achieves Major Milestone
- 7 Japan-India Collaboration on Space Debris Removal
- 8 IIT Bombay Unveils AroTrack
- 9 ‘One Day One Genome’ Initiative Unveiled
- 10 New Technology Enhances HIV Genome Detection
